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Background: The nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system produces superoxide. The -930A/G polymorphism is 
associated with hypertension, due to the fact that GG homozygotes produce less nitric oxide than AA/AG subjects. The role of this polymorphism on 
peripheral and central pressures in normotensive individuals has not been addressed yet.
Methods: 134 normotensive, euglycaemic, normolipidaemic individuals (85 males, age 41 years) were studied. The A-to-G substitution at position 
-930 in the p22phox promoter was typed by BbvI digestion of specific polymerase chain reaction products amplified from genomic DNA. The AA, AG 
and GG genotypes were determined. Peripheral pressures were measured by a mercury sphygmomanometer; aortic pressures were measured using 
applanation tonometry. ANOVA for multiple comparisons followed by Bonferonni correction was used.
Results: The prevalence of AA, AG and GG genotypes was 27.1%, 43.1% and 29.8%. When compared to AA subjects, AG and GG subjects 
demonstrated significantly higher levels of peripheral systolic blood pressure (PSBP) (AA: 109±13, AG: 118±13, GG: 116±12 mmH; p=0.007) and 
peripheral diastolic blood pressure (PDBP) (AA: 66±11, AG: 73±10, GG: 71±10 mmHg; p=0.007). Regarding central pressures, AA homozygotes had 
lower central systolic blood pressure (CSBP) (AA: 98±13, AG: 107±13, GG: 106±12 mmHg; p=0.002) and central diastolic blood pressure (CDBP) 
(AA: 67±11, AG: 75±10, GG: 72±10 mmHg; p=0.006). Multiple linear regression analysis revealed that age, sex, and presence of the G allele (AG or 
GG) were significant independent predictors of PSBP, PDBP, CSBP, CDBP (p<0.05 for all). Wave reflections, as measured by augmentation index did 
not vary across genotypes.
Conclusions: Our findings suggest that the -930A/G polymorphism of the p22phox promoter of NADPH oxidase is an independent determinant of 
both peripheral and central pressures in normotensive individuals. Presence of the G allele is associated with higher values of systolic and diastolic 
pressures both in the brachial artery and the aorta, even in normotensives. These findings elucidate the role of this polymorphism in the regulation 
of blood pressure.
